All news
Neutral impactCorporate Action

Glenmark Pharmaceuticals Limited — Record Date

NSE 3 hrs ago·31 Jul 2026, 1:23 pm
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited has announced that the company's record date for the upcoming dividend is set for August 31, 2026. This date is crucial as it determines which shareholders are eligible to receive the dividend payment. To qualify, investors must hold the shares in their demat accounts by the close of business on this specific day.

For investors, this announcement is primarily a notification of an upcoming corporate action. The declaration of a record date confirms that the dividend distribution is scheduled, though the actual payout will occur later. It serves as a reminder for shareholders to ensure their holdings are correctly registered to avoid missing out on the distribution.

Investors should keep an eye on the company's future announcements to confirm the final dividend amount and the specific payment date. While the record date is now set, the financial impact will depend on the final dividend declared by the board of directors.

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Glenmark Pharmaceuticals (GLENMARK).
  • Category: Corporate Action.

Why it matters

A routine update for Glenmark Pharmaceuticals. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.